Who invested in Sensydia?
Sensydia's investors include Colle Capital Partners, National Heart, Lung and Blood Institute and Orlando Health. Colle Capital Partners led its latest round.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$9.0Mraised across 2 rounds since 2023, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by PR Newswire: venture capitalSEC filing: $8.9M sold
Source recordedSEC filing: $7.8M sold, first sale May 2023
From Sensydia's own website and the SEC filings it signed: 3 on the team.
On the board, as filediAman J. MahajanDerrick SungErick HawkinsVictoria Grace
AdvisersWilliam A. Hawkins
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Sensydia's investors include Colle Capital Partners, National Heart, Lung and Blood Institute and Orlando Health. Colle Capital Partners led its latest round.
Sensydia has raised $9.0M across 2 rounds since 2023.
Sensydia's most recent round, $6.0M, was in Oct 2026, led by Colle Capital Partners.
Its most recent round, $6.0M in Oct 2026, is also its largest on record.
Sensydia's first round on record, in Jun 2023, was backed by Colle Capital Partners and National Heart, Lung and Blood Institute.
Sensydia's latest named round is a Grant, in Jun 2023.
Sensydia is based in the United States.
Colle Capital Partners led the funding round in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.